FOSUN PHARMA (02196) announced that, in order to further broaden financing channels, certain of its controlling subsidiaries plan to initiate new financing lease arrangements with qualified leasing or financial leasing companies. The total financing amount will not exceed RMB 650 million. The arrangements include: (1) sale and leaseback transactions using certain owned asset equipment as the transfer subject and leased assets, and (2) direct leasing for newly purchased asset equipment.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments